aidsmap - Robuta Search

https://www.aidsmap.com/ aidsmap | aidsmap aidsmap https://www.aidsmap.com/archive/all/hepatitis-hiv/elimination-hepatitis-c aidsmap aidsmap https://www.aidsmap.com/archive/about-hiv/testing-health-monitoring aidsmap aidsmap https://www.aidsmap.com/archive?content-type%5B%5D=news&topic%5B%5D=108 aidsmap aidsmap https://www.aidsmap.com/news/mar-2021/dolutegravir-superior-standard-care-treatment-children-and-adolescents Dolutegravir superior to standard-of-care treatment in children and adolescents | aidsmap Dolutegravir-based treatment was superior to treatment based on efavirenz or a boosted protease inhibitor in children and adolescents, both as first-line or... standard of care https://www.aidsmap.com/archive/editors-picks/prep/prep-policies-guidelines aidsmap aidsmap https://www.aidsmap.com/archive?content-type%5B%5D=editors-picks&topic%5B%5D=102 aidsmap aidsmap https://www.aidsmap.com/archive/news-all/health-services-systems/finance-funding aidsmap aidsmap https://www.aidsmap.com/archive/all/health-problems-ageing?page=24 aidsmap aidsmap https://www.aidsmap.com/archive?content-type%5B0%5D=news&content-type%5B1%5D=editors-picks&country%5B0%5D=10689 aidsmap aidsmap https://www.aidsmap.com/news/nov-2022/low-testosterone-linked-efavirenz-increased-body-fat-and-older-age Low testosterone is linked to efavirenz, increased body fat and older age | aidsmap A French study of men living with well-controlled HIV identified risk factors for low testosterone. It found that being aged over 43, use of efavirenz as... https://www.aidsmap.com/archive/editors-picks/testing-health-monitoring?page=16 aidsmap aidsmap https://www.aidsmap.com/news/feb-2009/seminal-hiv-cell-free-virus-not-infected-cells-leads-transmission-between-men Seminal HIV: cell-free virus, not infected cells, leads to transmission between men | aidsmap At the Sixteenth Conference on Retroviruses and Opportunistic Infections in Montreal on Monday morning, David Butler of the University of California San Diego... https://www.aidsmap.com/news/sep-2022/nevirapine-treatment-linked-poorer-cognitive-development-children-hiv Nevirapine treatment linked to poorer cognitive development in children with HIV | aidsmap Children with HIV treated with nevirapine before the age of three had significantly lower scores on neuropsychological tests between the ages of five and... cognitive development https://www.aidsmap.com/about-hiv/arv-background-information/descovy Descovy | aidsmap Descovy is a fixed-dose tablet combining 200mg of emtricitabine and either 25mg or 10mg of tenofovir alafenamide (TAF). descovy aidsmap https://www.aidsmap.com/news/jan-2014/opt-out-hiv-testing-acute-medical-admissions-uk-hospitals-works Opt-out HIV testing for acute medical admissions to UK hospitals works | aidsmap Opt-out HIV testing for general medical admissions to hospital is feasible, cost-effective and leads to the identification of previously undiagnosed... https://www.aidsmap.com/about-hiv/how-effective-post-exposure-prophylaxis-pep How effective is post-exposure prophylaxis (PEP)? | aidsmap PEP is a four-week course of medication that may block HIV infection after exposure to the virus. post exposure prophylaxis effective pep aidsmap https://www.aidsmap.com/archive/all/social-legal-issues/confidentiality-consent-medical-ethics aidsmap aidsmap https://www.aidsmap.com/about-hiv/bone-loss-osteoporosis-and-hiv Bone loss, osteoporosis, and HIV | aidsmap Rates of osteopenia and osteoporosis are higher in people living with HIV than in the general population. bone loss osteoporosis hiv aidsmap https://www.aidsmap.com/archive/news-all/health-problems-ageing/low-cd4-count aidsmap aidsmap https://www.aidsmap.com/archive/all/hiv-treatment/injectable-long-acting-hiv-treatment aidsmap aidsmap https://www.aidsmap.com/about-hiv/faq/what-viral-load-blip-and-does-it-matter What is a viral load blip, and does it matter? | aidsmap A viral blip is a reference to a short-term increase in viral load in someone who generally maintains an undetectable viral load. This means that the amount of... does it matter what is viral load https://www.aidsmap.com/archive?content-type%5B0%5D=news&content-type%5B1%5D=editors-picks&country%5B0%5D=11479 aidsmap aidsmap https://www.aidsmap.com/news/feb-2017/legalisation-sex-work-associated-lower-prevalence-hiv-sex-workers Legalisation of sex work associated with lower prevalence of HIV in sex workers | aidsmap Countries that have legalised some aspects of sex work have fewer sex workers living with HIV than countries that criminalise all aspects of sex work,... sex work associated with https://www.aidsmap.com/news/dec-2015/9-month-mdr-tb-regimen-cures-82-african-study 9-month MDR-TB regimen cures 82% in African study | aidsmap A 9-month standardised treatment regimen for multi-drug resistant tuberculosis (MDR-TB) cured 82% of people recruited to an observational study in Francophone... 9 month mdr tb regimen https://www.aidsmap.com/news/feb-2012/fat-accumulation-linked-cognitive-impairment-patients-hiv Fat accumulation linked to cognitive impairment in patients with HIV | aidsmap Central fat accumulation is associated with an increased risk of neurocognitive impairment for HIV-positive patients, according to a study published in the... fat accumulation cognitive impairment in patients linked https://www.aidsmap.com/videos/aidsmaplive-hiv-stigma-special aidsmapLIVE: HIV stigma special | aidsmap With activist, speaker and writer Bisi Alimi; Kat Smithson from the National AIDS Trust; community activist Memory Sachikonye; NAM aidsmap's Executive Director... hiv stigma special aidsmap https://www.aidsmap.com/news/oct-2023/making-pep-available-community-could-reduce-new-hiv-cases-africa-31 Making PEP available in the community could reduce new HIV cases in Africa by 31% | aidsmap Making the commonly prescribed antiretroviral regimen of tenofovir, lamivudine and dolutegravir available in the community as post-exposure prophylaxis after... https://www.aidsmap.com/news/feb-2024/cd4cd8-ratio-useful-test-people-hiv Is the CD4/CD8 ratio a useful test for people with HIV? | aidsmap Monitoring of CD4/CD8 ratios should not be abandoned as HIV treatment programmes switch to streamlined monitoring, researchers from the University of Wisconsin... cd4 cd8 ratio https://www.aidsmap.com/archive?content-type%5B%5D=editors-picks&conference%5B%5D=591 aidsmap aidsmap https://www.aidsmap.com/news/nov-2019/work-needed-improve-long-term-retention-care-mozambique Work needed to improve long-term retention in care in Mozambique | aidsmap A recent mixed methods study conducted in Mozambique found that three-quarters of individuals diagnosed HIV positive reported enrolling in care after their... long term in care work needed improve https://www.aidsmap.com/about-hiv/how-much-does-hiv-treatment-cost-nhs How much does HIV treatment cost the NHS? | aidsmap In the UK, HIV treatment and care are provided free to all patients who need it. But since health budgets are limited, it is useful for policy makers to... how much does hiv treatment the nhs cost aidsmap https://www.aidsmap.com/news/mar-2011/zinc-finger-gene-therapy-produces-hiv-resistant-cd4-t-cells Zinc finger gene therapy produces HIV-resistant CD4 T-cells | aidsmap Gene therapy that interferes with co-receptors on the surface of T-cells can protect these cells from HIV infection, representing a potential first step toward... cd4 t cells zinc finger gene therapy produces https://www.aidsmap.com/archive/editors-picks/healthy-living/mental-emotional-health-wellbeing aidsmap aidsmap https://www.aidsmap.com/news/apr-2018/loneliness-and-community-are-key-chemsex Loneliness and community are key to chemsex | aidsmap The second European Chemsex Forum, recently held in Berlin, highlighted how the perspectives of activists and health professionals working on the issue have... loneliness community key chemsex aidsmap https://www.aidsmap.com/archive/about-hiv/populations/women aidsmap aidsmap https://www.aidsmap.com/?content-type%5B0%5D=editors-picks&topic%5B0%5D=14488&page=6 aidsmap | aidsmap aidsmap https://www.aidsmap.com/archive/news-all/hiv-treatment/people-limited-treatment-options aidsmap aidsmap https://www.aidsmap.com/conferences/ias-2023 IAS 2023 | aidsmap News and research from the 12th International AIDS Society Conference on HIV Science (IAS 2023). ias 2023 aidsmap https://www.aidsmap.com/?content-type%5B0%5D=news&topic%5B0%5D=14445&page=0 aidsmap | aidsmap aidsmap https://www.aidsmap.com/news/jul-2023/statins-and-hiv-how-can-reprieve-findings-be-implemented-real-world Statins and HIV: how can the REPRIEVE findings be implemented in the real world? | aidsmap Findings from the landmark REPRIEVE trial, which tested a daily statin medication for people living with HIV, were presented on Monday at the 12th... https://www.aidsmap.com/conferences/croi-2026 CROI 2026 | aidsmap News and research from the 33rd Conference on Retroviruses and Opportunistic Infections (CROI 2026), which is being held in Denver, US, from 22 to 25 February. croi 2026 aidsmap https://www.aidsmap.com/archive/news-all/populations?page=39 aidsmap aidsmap https://www.aidsmap.com/news/feb-2008/hivhepatitis-b-coinfection-africa-posing-dilemma-3tc-based-art HIV/hepatitis B coinfection in Africa posing dilemma for 3TC-based ART | aidsmap Over 10% of infants in Cote D'Ivoire are coinfected with HIV and hepatitis B virus, according to the findings of a study published in the February 1st edition... https://www.aidsmap.com/languages/croatian Croatian | aidsmap These are translations and adaptations of information originally written in English by NAM aidsmap. croatian aidsmap https://www.aidsmap.com/?content-type%5B0%5D=news&topic%5B0%5D=157&page=6 aidsmap | aidsmap aidsmap https://www.aidsmap.com/archive/editors-picks/healthy-living?page=7 aidsmap aidsmap https://www.aidsmap.com/videos/information-young-people-how-my-hiv-medication-works Information for young people: How my HIV medication works | aidsmap An animation describing how HIV medication works. This video was created by Chiva, in collaboration with aidsmap and supported by a ViiV Healthcare grant. information for young people hiv medication works aidsmap https://www.aidsmap.com/about-hiv/glossary Glossary | aidsmap We all sometimes see words we don't recognise, or don't understand. If you have suggestions for words or phrases we could add, we would love to hear from you. glossary aidsmap https://www.aidsmap.com/conferences/croi-2011 CROI 2011 | aidsmap News and research from the 18th Conference on Retroviruses and Opportunistic Infections (CROI 2011), which took place in Boston, USA, 27th February-2nd March... croi 2011 aidsmap https://www.aidsmap.com/news/mar-2012/superinfection-second-hiv-infections-happen-often-first-ones Superinfection: second HIV infections happen as often as first ones | aidsmap Two studies of people with HIV in Rakai, Uganda and Mombasa, Kenya presented at the 19th Conference on Retroviruses and Opportunistic Infections show that the... hiv infections first ones superinfection second happen https://www.aidsmap.com/?content-type%5B0%5D=news&content-type%5B1%5D=editors-picks&country%5B0%5D=11495&page=0 aidsmap | aidsmap aidsmap https://www.aidsmap.com/?content-type%5B0%5D=news&content-type%5B1%5D=editors-picks&country%5B0%5D=11707&page=7 aidsmap | aidsmap aidsmap https://www.aidsmap.com/archive/all/health-services-systems?page=62 aidsmap aidsmap https://www.aidsmap.com/news/mar-2011/hiv-drug-resistance-spreading-early-warning-signals-say-yes Is HIV drug resistance spreading? Early warning signals say 'yes' | aidsmap Signals warning of the transmission of drug-resistant HIV are growing in low- and middle-income countries, and governments should step up surveillance efforts... hiv drug resistance early warning say yes spreading https://www.aidsmap.com/news/jul-2012/adolescent-antiretroviral-options-expanding Adolescent antiretroviral options expanding | aidsmap A range of new antiretroviral drugs are in development for adolescents with HIV, a population which may have extensive experience of antiretroviral therapy and... adolescent antiretroviral options expanding aidsmap https://www.aidsmap.com/news/nov-2015/triple-daa-regimen-cures-hepatitis-c-patients-rapid-response-just-3-weeks Triple DAA regimen cures hepatitis C patients with rapid response in just 3 weeks | aidsmap Response-guided therapy using an all-oral regimen of three direct-acting antivirals cured a majority of easier-to-treat genotype 1b hepatitis C patients in... https://www.aidsmap.com/archive?content-type%5B%5D=editors-picks&topic%5B%5D=70 aidsmap aidsmap https://www.aidsmap.com/news/feb-2020/does-prep-cause-more-hiv-drug-resistance-yes-some Does PrEP cause more HIV drug resistance? Yes, some | aidsmap A case note review from 56 Dean Street, the largest HIV and STI clinic in Europe, has found that former PrEP users who get HIV are more likely to have a... hiv drug resistance prep cause yes aidsmap https://www.aidsmap.com/news/mar-2020/community-based-hiv-treatment-superior-clinic-based-care-men-south-africa Community-based HIV treatment superior to clinic-based care for men in South Africa | aidsmap Starting antiretroviral treatment on the day of diagnosis in a community setting and picking up medication from a mobile van resulted in superior rates of... https://www.aidsmap.com/news/dec-2017/hiv-positive-transgender-men-us-have-significant-unmet-medical-and-social-needs HIV-positive transgender men in US have significant unmet medical and social needs | aidsmap HIV-positive transgender men in the United States have significant unmet social and healthcare needs, according to a study published in Research and Practice.... https://www.aidsmap.com/news/oct-2015/no-transmission-integrase-inhibitor-resistant-hiv-seen-california-patients No transmission of integrase inhibitor-resistant HIV seen in California patients | aidsmap Not one case of transmission of HIV that is resistant to any of the integrase inhibitor (INI) drugs has been seen in newly-diagnosed patients in a database of... integrase inhibitor https://www.aidsmap.com/videos/aidsmaplive-hiv-sex-relationships aidsmapLIVE: HIV, sex & relationships | aidsmap With writer and activist, Tom Hayes; mentor, speaker and trainer, Rebecca Mbewe; TV doctor and consultant physician in sexual health, Dr Naomi Sutton;... sex relationships hiv aidsmap https://www.aidsmap.com/news/may-2017/hydromorphone-works-well-heroin-assisted-drug-addiction-treatment Hydromorphone works as well as heroin-assisted drug addiction treatment | aidsmap Hydromorphone was as effective as pharmaceutical heroin for opioid addiction treatment, but it was associated with fewer serious side-effects, according to... drug addiction treatment hydromorphone works well heroin https://www.aidsmap.com/news/jul-2022/nationwide-australian-data-shows-prep-has-largely-neutral-effect-sti-incidence Nationwide Australian data shows PrEP has largely neutral effect on STI incidence | aidsmap The largest study ever of the incidence of bacterial sexually transmitted infections (STIs) among gay and bisexual men who start HIV pre-exposure prophylaxis... https://www.aidsmap.com/news/may-2021/same-day-art-initiation-linked-increased-risk-negative-outcomes Same-day ART initiation linked to increased risk of negative outcomes | aidsmap Same-day initiation of antiretroviral therapy after diagnosis has some negative effects, including more patients lost to follow-up, according to a study... same day https://www.aidsmap.com/news/may-2013/majority-italian-hiv-specialists-would-prescribe-prep Majority of Italian HIV specialists would prescribe PrEP | aidsmap Seventy per cent of Italian HIV specialists who answered an online survey would prescribe pre-exposure prophylaxis (PrEP) to people in their care who ask for... majority italian hiv specialists would https://www.aidsmap.com/news/jul-2018/dolutegravir-update-infant-neural-tube-defects-botswana Dolutegravir: update on infant neural tube defects from Botswana | aidsmap Dolutegravir treatment at the time of conception is associated with a higher risk of neural tube defects in infants exposed to the drug when compared to... neural tube defects dolutegravir update infant botswana https://www.aidsmap.com/news/jun-2018/frailty-men-hiv-linked-bone-weakness-muscle-loss-and-large-waist Frailty in men with HIV linked with bone weakness, muscle loss and large waist | aidsmap Frailty is twice as prevalent in middle-aged and elderly HIV-positive men as in their HIV-negative peers, investigators from the Multicenter AIDS Cohort Study... https://www.aidsmap.com/conferences/hivr4p-2016 HIVR4P 2016 | aidsmap News and research from the HIV Research for Prevention conference (HIVR4P), which took place in Chicago, USA from 17-21 October 2016. 2016 aidsmap https://www.aidsmap.com/archive/editors-picks/healthy-living?page=4 aidsmap aidsmap https://www.aidsmap.com/news/jun-2024/matthew-hodson-stands-down-aidsmaps-executive-director-after-8-years Matthew Hodson stands down as aidsmap's Executive Director after 8 years | aidsmap Matthew Hodson has decided to stand down as Executive Director of aidsmap. This marks the end of a significant era for the organisation and the HIV community.... https://www.aidsmap.com/topic/health-services-systems Health services & systems | aidsmap Getting the most from doctors, nurses, pharmacists and other healthcare providers. health services systems aidsmap https://www.aidsmap.com/news/mar-2001/40-new-infections-women 40% of new infections in women... | aidsmap 40% of new infections globally are now occuring in women, according to American epidemiologist Prof. Kenrad Nelson. It is well known that the gender disparity... 40 of new infections women aidsmap https://www.aidsmap.com/?content-type%5B0%5D=editors-picks&topic%5B0%5D=73&page=1 aidsmap | aidsmap aidsmap https://www.aidsmap.com/news/apr-2016/portugals-roll-out-hcv-therapy-daas-achieves-impressive-results Portugal's roll-out of HCV therapy with DAAs achieves impressive results | aidsmap Roll-out of hepatitis C virus (HCV) therapy using direct acting antivirals (DAAs) has achieved excellent outcomes in Portugal, data presented to the... https://www.aidsmap.com/about-hiv/arv-background-information/efavirenzemtricitabinetenofovir-disoproxil-fumarate Efavirenz/emtricitabine/tenofovir disoproxil fumarate | aidsmap A fixed-dose tablet combining 600mg efavirenz, 200mg emtricitabine and 245mg tenofovir. The standard dose is one tablet once a day. tenofovir disoproxil fumarate efavirenz emtricitabine aidsmap https://www.aidsmap.com/news/jul-2013/text-messages-mothers-improve-early-infant-hiv-diagnosis-rates-kenya-and-mozambique Text messages to mothers improve early infant HIV diagnosis rates in Kenya and Mozambique | aidsmap Use of text messaging significantly improved the rate of early infant diagnosis (EID) among HIV-positive pregnant women enrolled in a prevention of... https://www.aidsmap.com/news/sep-2021/successful-prep-interventions-marginalised-communities-ashodaya-prep-project?fbclid=IwAR1xNOh5XT4fp5d3IFU40Zsqoa4CN-kSja4WEmbslWqtMfIE_1-E0h2YGSI Successful PrEP interventions in marginalised communities: the Ashodaya PrEP Project | aidsmap Community mobilisation and ownership were central to the success of a PrEP demonstration project conducted with female sex workers in Mysore, India, a recent... marginalised communities successful prep interventions project https://www.aidsmap.com/news/feb-2018/zambia-hiv-deaths-treatment-underestimated Zambia: HIV deaths on treatment underestimated | aidsmap People with HIV in Zambia were at least ten times more likely to die in the first two years after starting antiretroviral treatment than European patients,... zambia hiv deaths treatment underestimated https://www.aidsmap.com/?content-type%5B0%5D=editors-picks&topic%5B0%5D=108&page=4 aidsmap | aidsmap aidsmap https://www.aidsmap.com/news/apr-2010/cheap-antibiotic-halves-risk-death-first-18-months-antiretroviral-treatment Cheap antibiotic halves risk of death in first 18 months of antiretroviral treatment | aidsmap Use of cotrimoxazole, a cheap and widely available antibiotic, cut the death rate by half in the first 72 weeks on antiretroviral therapy in over 3000... https://www.aidsmap.com/about-hiv/undetectable-viral-load-and-hiv-transmission Undetectable viral load and HIV transmission | aidsmap Having an undetectable viral load means that there is not enough of the virus in body fluids to pass on HIV during sex. This is sometimes referred to as 'U=U'. viral load hiv transmission undetectable aidsmap https://www.aidsmap.com/archive/about-hiv/healthy-living aidsmap aidsmap https://www.aidsmap.com/archive/news-all/testing-health-monitoring/taking-hiv-test aidsmap aidsmap https://www.aidsmap.com/archive/all/transmission-prevention aidsmap aidsmap https://www.aidsmap.com/news/may-2024/hidden-hepatitis-b-infection-may-compromise-dolutegravir-lamivudine-treatment Hidden hepatitis B infection may compromise dolutegravir / lamivudine treatment | aidsmap Having a hidden infection with hepatitis B may undermine viral suppression after a switch to dolutegravir / lamivudine (Dovato), a study of people with HIV who... hepatitis b dolutegravir lamivudine hidden infection may https://www.aidsmap.com/videos/aidsmapchat-series-1-episode-7 aidsmapCHAT: series 1, episode 7 | aidsmap With Shannon Hader, Deputy Executive Director of Programme at UNAIDS; Winifred lkilai, who works with the AIDS Vaccine Advocacy Coalition (AVAC); and Julia... series 1 episode 7 aidsmap https://www.aidsmap.com/about-hiv/how-accurate-are-rapid-point-care-tests-hiv How accurate are rapid, point-of-care tests for HIV? | aidsmap Rapid tests are usually reliable for long-standing infections, but are sometimes unable to detect recent HIV infections acquired in the past few weeks. point of care tests accurate rapid https://www.aidsmap.com/friend Friends of aidsmap | aidsmap friends of aidsmap https://www.aidsmap.com/news/dec-2015/grazoprevirelbasvir-cures-more-90-people-hivhcv-co-infection Grazoprevir/elbasvir cures more than 90% of people with HIV/HCV co-infection | aidsmap Merck's grazoprevir/elbasvir combination cured 93% of people with HIV and hepatitis C co-infection, was well-tolerated and did not appear to interact with... hiv hcv co infection https://www.aidsmap.com/archive/news-all/pregnancy-children-young-people?page=1 aidsmap aidsmap https://www.aidsmap.com/archive?content-type%5B0%5D=news&content-type%5B1%5D=editors-picks&country%5B0%5D=11430 aidsmap aidsmap https://www.aidsmap.com/archive/about-hiv/populations/transgender-people aidsmap aidsmap https://www.aidsmap.com/news/jan-2017/tenofovir-alafenamide-approved-hepatitis-b-europe Tenofovir alafenamide approved for hepatitis B in Europe | aidsmap The European Commission this week granted marketing authorisation for tenofovir alafenamide, to be sold under the brand name Vemlidy, for the treatment of... tenofovir alafenamide hepatitis b in europe approved aidsmap https://www.aidsmap.com/news/mar-2012/telaprevir-and-boceprevir-boost-sustained-response-rates-hivhcv-coinfected Telaprevir and boceprevir boost sustained response rates for HIV/HCV coinfected | aidsmap Adding a first-generation hepatitis C virus (HCV) protease inhibitor to pegylated interferon/ribavirin dramatically increases the likelihood of 12-week... response rates https://www.aidsmap.com/news/sep-2023/very-poor-long-term-outcomes-people-tb-and-hiv-eastern-europe Very poor long-term outcomes for people with TB and HIV in Eastern Europe | aidsmap The rates of tuberculosis (TB) recurrence and mortality in people with HIV in eastern Europe remain concerningly high and continue to be a clinical and public... https://www.aidsmap.com/about-hiv/anxiety-and-hiv Anxiety and HIV | aidsmap Life with HIV can at times involve worry and uncertainty. Anxiety can be a natural response to a new development in life when you are not familiar with it. anxiety hiv aidsmap https://www.aidsmap.com/archive/news-all/healthy-living/quality-life aidsmap aidsmap https://www.aidsmap.com/news/apr-2016/tenofovir-alafenamide-works-well-against-hepatitis-b-less-effect-bones-and-kidneys Tenofovir alafenamide works well against hepatitis B with less effect on bones and kidneys | aidsmap The new tenofovir alafenamide (TAF) pro-drug is as potent against hepatitis B virus (HBV) as the current tenofovir disoproxil fumarate (TDF) formulation, but...